The company in the historic notebook benefits from an upgrade that arrived after the publication of positive quarterly accounts - For Pierrel, on the other hand, the signing of an agreement for the distribution of a drug in the United States is decisive.
The capital increase envisaged by Pierrel concluded on 5 December with a subscription of 74,4% - The share goes up on the stock market
US and Canadian dentists, new customers of Pierrel who recently landed in North America with the flagship product Orabloc, push the sales of the Italian group to improve by a third in September - Title over +3% in…
At the end of July, the total loss was almost 18,8 million euros - The targets for 2013 and 2014 were confirmed.